Patents by Inventor Gary Krantz

Gary Krantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6975892
    Abstract: The present invention is related to non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject by measuring electromagnetic radiation signatures from the subject's conjunctiva. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument floods the conjunctiva of the subject with electromagnetic radiation in the mid-infrared range and measures analyte concentrations based on mid-infrared radiation reflected back to the instrument.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: December 13, 2005
    Assignee: Oculir, Inc.
    Inventors: John F. Burd, Gary Krantz, Jacob Fraden, Charles Kramer, Bart Chapman, William Sell
  • Patent number: 6968222
    Abstract: The present invention is related to optical non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument floods a body surface of the subject, such as the subject's eye, with radiation in the mid-infrared range and measures analyte concentrations based on mid-infrared radiation reflected back to the instrument.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: November 22, 2005
    Assignee: Oculir, Inc.
    Inventors: John F. Burd, Jacob Fraden, Charles E. Kramer, Gary Krantz, William Sell
  • Patent number: 6958039
    Abstract: The present invention is related to optical non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument measures the level of mid-infrared radiation from the subject's body surface, such as the eye, and determines a specific analyte's concentration based on said analyte's distinctive mid-infrared radiation signature.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: October 25, 2005
    Assignee: Oculir, Inc.
    Inventors: John F. Burd, Gary Krantz, William Sell
  • Publication number: 20050085701
    Abstract: The present invention is related to non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject by measuring electromagnetic radiation signatures from the subject's conjunctiva. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument floods the conjunctiva of the subject with electromagnetic radiation in the mid-infrared range and measures analyte concentrations based on mid-infrared radiation reflected back to the instrument.
    Type: Application
    Filed: April 14, 2004
    Publication date: April 21, 2005
    Inventors: John Burd, Gary Krantz, Jacob Fraden, Charles Kramer, Bart Chapman, William Sell
  • Publication number: 20040220457
    Abstract: The present invention is related to optical non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument floods a body surface of the subject, such as the subject's eye, with radiation in the mid-infrared range and measures analyte concentrations based on mid-infrared radiation reflected back to the instrument.
    Type: Application
    Filed: May 2, 2003
    Publication date: November 4, 2004
    Inventors: John F. Burd, Jacob Fraden, Charles E. Kramer, Gary Krantz, William Sell
  • Publication number: 20040220458
    Abstract: The present invention is related to optical non-invasive methods and instruments to detect the level of analyte concentrations in the tissue of a subject. The spectra of mid-infrared radiation emitted from a subject's body are altered corresponding to the concentration of various compounds within the radiating tissue. In one aspect of the invention, an instrument measures the level of mid-infrared radiation from the subject's body surface, such as the eye, and determines a specific analyte's concentration based on said analyte's distinctive mid-infrared radiation signature.
    Type: Application
    Filed: April 14, 2004
    Publication date: November 4, 2004
    Inventors: John F. Burd, Gary Krantz, William Sell
  • Publication number: 20010051352
    Abstract: A multilayer test strip includes a first layer having an indicator reagent within a porous substrate, a second layer, overlying the first layer, including a reactive reagent, and a third layer, overlying the second layer, including a spreading agent that promotes the spreading of a liquid upon the third layer. Alternatively, the spreading agent may be mixed into the second layer. An inert backing with an aperture therethrough is positioned over these layers, with the substrate remote from the cover layer.
    Type: Application
    Filed: April 15, 1993
    Publication date: December 13, 2001
    Inventors: GARY KRANTZ, S.T. CHEN, ADAM ZIPP, JOANNE ZENG
  • Patent number: 5755231
    Abstract: A test strip includes a first layer and an overlying differential flow-retarding layer that reduces the fraction of a component of a liquid specimen percolated therethrough. An inert backing, preferably having an aperture therethrough, overlies the flow-retarding layer. For the testing of a blood specimen, the flow-retarding layer is formed of glass fibers that reduce the fraction of red blood cells in the percolate, leaving primarily, but not entirely, plasma in the percolate. The first layer includes chemicals that react with a component of the plasma such as glucose in a measurable reaction, preferably a visually measurable reaction. In using this test strip, the blood specimen is placed into the aperture of the backing and permitted to percolate through the flow-retarding layer such that a fraction of the red blood cells is removed from the percolate.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: May 26, 1998
    Assignee: Plus Bio, Inc.
    Inventors: Gary Krantz, Shuenn-Tzong Chen, Adam Zipp, Joanne Zeng
  • Patent number: D342030
    Type: Grant
    Filed: February 12, 1991
    Date of Patent: December 7, 1993
    Inventor: Gary Krantz